Synaptotagmin Binding to Botulinum Neurotoxins.


Journal

Biochemistry
ISSN: 1520-4995
Titre abrégé: Biochemistry
Pays: United States
ID NLM: 0370623

Informations de publication

Date de publication:
04 02 2020
Historique:
pubmed: 7 12 2019
medline: 22 8 2020
entrez: 7 12 2019
Statut: ppublish

Résumé

Botulinum neurotoxins (BoNTs) are exceptionally toxic proteins that cause paralysis but are also extensively used as treatment for various medical conditions. Most BoNTs bind two receptors on neuronal cells, namely, a ganglioside and a protein receptor. Differences in the sequence between the protein receptors from different species can impact the binding affinity and toxicity of the BoNTs. Here we have investigated how BoNT/B, /DC, and /G, all three toxins that utilize synaptotagmin I and II (Syt-I and Syt-II, respectively) as their protein receptors, bind to Syt-I and -II of mouse/rat, bovine, and human origin by isothermal titration calorimetry analysis. BoNT/G had the highest affinity for human Syt-I, and BoNT/DC had the highest affinity for bovine Syt-II. As expected, BoNT/B, /DC, and /G showed very low levels of binding to human Syt-II. Furthermore, we carried out saturation transfer difference (STD) and STD-TOCSY NMR experiments that revealed the region of the Syt peptide in direct contact with BoNT/G, which demonstrate that BoNT/G recognizes the Syt peptide in a model similar to that in the established BoNT/B-Syt-II complex. Our analyses also revealed that regions outside the Syt peptide's toxin-binding region are important for the helicity of the peptide and, therefore, the binding affinity.

Identifiants

pubmed: 31809018
doi: 10.1021/acs.biochem.9b00554
doi:

Substances chimiques

Gangliosides 0
Neurotoxins 0
Synaptotagmins 134193-27-4
Botulinum Toxins EC 3.4.24.69
Botulinum Toxins, Type A EC 3.4.24.69

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

491-498

Subventions

Organisme : NIAID NIH HHS
ID : U54 AI057159
Pays : United States

Auteurs

Markel Martínez-Carranza (M)

Department of Biochemistry and Biophysics , Stockholm University , SE-106 91 Stockholm , Sweden.

Pilar Blasco (P)

Department of Organic Chemistry , Stockholm University , SE-106 91 Stockholm , Sweden.

Robert Gustafsson (R)

Department of Biochemistry and Biophysics , Stockholm University , SE-106 91 Stockholm , Sweden.

Min Dong (M)

Department of Urology, Boston's Children Hospital, and Department of Microbiology and Immunology and Department of Surgery , Harvard Medical School , Boston , Massachusetts 02115 , United States.

Ronnie Per-Arne Berntsson (RP)

Department of Medical Biochemistry and Biophysics , Umeå University , SE-90187 Umeå , Sweden.
Wallenberg Centre for Molecular Medicine , Umeå University , SE-90187 Umeå , Sweden.

Göran Widmalm (G)

Department of Organic Chemistry , Stockholm University , SE-106 91 Stockholm , Sweden.

Pål Stenmark (P)

Department of Biochemistry and Biophysics , Stockholm University , SE-106 91 Stockholm , Sweden.
Department of Experimental Medical Science , Lund University , SE-221 00 Lund , Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH